Genome Editing Market share to see growth of 14% from 2016 to 2024 - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

Genome Editing Market share to see growth of 14% from 2016 to 2024

Description:

Get more details @ Major industry participants for the global gene editing market share include Agilent Technologies, Allele Biotech, AstraZeneca, Bio Rad, Cellectis, CRISPR Therapeutics, Editas Medicine, GE Healthcare Dharmacon, Lonza, Qiagen, Recombinetics, Sigma-Aldrich and Thermo Fisher Scientific. – PowerPoint PPT presentation

Number of Views:47

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Genome Editing Market share to see growth of 14% from 2016 to 2024


1
Genome Editing Market to grow at 14 CAGR from
2016 to 2024 Fractovia.org
2
Key Insights of Genome Editing Market
  • Global Market Insights, Inc. says, Genome editing
    industry value, worth USD 2.17 billion in 2015,
    is set to hit USD 7.5 billion by 2024.
  • Genome editing market revenue is anticipated to
    witness a notable surge over the years ahead,
    driven by the escalating occurrence of cancer and
    other genetic inherited disorders coupled with
    mounting demand for personalized medicines.
  • Companies have been spending extensively on RD
    activities across the pharma biotech sectors.
  • Considering the geographical landscape, U.S.
    genome editing market, worth USD 518.5 million in
    2015, is slated to expand considerably in the
    future.
  • UK genome editing industry is projected to cross
    a revenue of USD 744 million by 2024, registering
    a CAGR of 14.9 over 2016-2024. The high
    occurrence of chronic disorders among the rising
    old population will propel the industry
    development.

3
Continued
  • Japan genome editing market revenue, worth USD
    160 million in 2015, is projected to grow at a
    rate of 15 over the coming timeframe.
  • Improvement in healthcare amenities and favorable
    government policies to restrict the spread of
    infectious diseases will push the business
    expansion.
  • Hematology, which contributed USD 807 million
    towards gene editing industry share in 2015, is
    expected to make notable contributions towards
    the industry revenue even in the future.
  • Biotech pharma firms, contract research
    organizations, and research institutes are the
    key end-users of genome editing industry.
  • Genome editing makes use of technologies such as
    meganucleases, CRISPR/Cas9, TALENS, and zinc
    finger nucleases. CRISPR technology, which
    dominated the overall market in 2015, is set to
    surpass USD 3 billion by 2024.
  • Bio Rad Laboratories Inc., Editas Medicine,
    Sigma-Aldrich, Thermo Fisher Scientific, and
    Allele Biotechnology are the major players of
    gene editing market.

4
U.S. Gene Editing Market Size, by Application,
2013- 2024 (USD Million)

5

Browse Full Market Research Report of Genome
Editing Market _at_ http//bit.ly/2tY7J4N
Request for a Sample of this Research report
_at_ https//www.fractovia.org/request-sample/499
6
Table of Contents
Chapter 1. Methodology and Scope 1.1
Research Methodology 1.1.1 Initial
data exploration 1.1.2 Statistical modeling and
forecast 1.1.3 Industry insights and
validation 1.1.4 Research scope and assumptions
1.2
Data Sources 1.2.1 Primary sources 1.2.2
Secondary sources Chapter 2. Executive
Summary 2.1 Gene Editing industry 3600
synopsis, 2013 - 2024 2.1.1 Business
trends 2.1.2 Application trends 2.1.3
Technology trends 2.1.4 End User trends 2.1.5
Regional trends
7
Continued
Chapter 3. Gene Editing Industry Insights 3.1
Industry segmentation 3.2 Industry Size and
forecast, 2013 2024 3.3 Industry ecosystem
analysis 3.3.1 Vendor matrix 3.4 Industry
Impact forces 3.4.1 Growth drivers 3.4.1.1
Increased funding for genetics research 3.4.1.2
Increased RD expenditure and growth of
biotechnology 3.4.1.3 Increasing demand for
synthetic genes 3.4.1.4 Growing use of
genetically modified technology 3.4.1.5
Technology advancements 3.4.2 Industry
pitfalls challenges 3.4.2.1 Stringent
government regulations 3.4.2.2 Dearth of
public awareness
8
Continued
3.5 Regulatory trends 3.5.1 U.S. 3.5.2
Europe 3.5.3 China 3.6 Growth potential
analysis 3.7 Company market share analysis,
2015 3.7.1 Strategy dashboard 3.8 Porters
analysis 3.9 PESTEL analysis
9
Stay In Touch Website https//www.fractovia.org
Social Media
About PowerShow.com